LK-423

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameLK-423
Drug Alias NameLEK-423
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-10 stimulants
TargetsInterleukin-10
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFujimoto Pharmaceutical
Active IndicationsN/A
Inactive IndicationsColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A